Pathological complete response to neoadjuvant pembrolizumab in a patient with metastatic cutaneous squamous cell carcinoma

J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1318-e1320. doi: 10.1111/jdv.19307. Epub 2023 Jul 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / drug therapy
  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms*
  • Humans
  • Neoadjuvant Therapy
  • Skin Neoplasms* / drug therapy

Substances

  • pembrolizumab